Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients with Moderate to Severe Dry Eye Disease (2021)

First Author: Holland EJ

Attributed to: Understanding the molecular and cellular complexity of human cornea through single cell analyses funded by SPF

No abstract provided

Type: Journal Article/Review

Volume: 139

Parent Publication: JAMA Ophthalmology

Issue: 11